Unlocking the potential of drug-drug cocrystals – A comprehensive review
- 14 June 2022
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 348, 456-469
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Polymorphs, Salts, and Cocrystals: What’s in a Name?Crystal Growth & Design, 2012
- Application of Twin Screw Extrusion in the Manufacture of Cocrystals, Part I: Four Case StudiesPharmaceutics, 2011
- Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis TreatmentPLOS Neglected Tropical Diseases, 2009
- Co-Crystals of the Anti-HIV Drugs Lamivudine and ZidovudineCrystal Growth & Design, 2008
- Supramolecular Synthesis Based on a Combination of Hydrogen and Halogen BondsCrystal Growth & Design, 2008
- Polymorphism in Carbamazepine CocrystalsCrystal Growth & Design, 2008
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Building co-crystals with molecular sense and supramolecular sensibilityCrystEngComm, 2005
- Hybrid insulin cocrystals for controlled release deliveryNature Biotechnology, 2002
- The crystal and molecular structure of the 2:1 molecular complex of theophylline with phenobarbitalActa crystallographica Section B, Structural science, crystal engineering and materials, 1977